Regencell Bioscience Holdings Ltd

NASDAQ RGC

Download Data

Regencell Bioscience Holdings Ltd Price to Sales Ratio (P/S) on June 03, 2024

Regencell Bioscience Holdings Ltd Price to Sales Ratio (P/S) is NA on June 03, 2024, a NA change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.
  • Regencell Bioscience Holdings Ltd 52-week high Price to Sales Ratio (P/S) is -0.04 on February 09, 2024, which is NA below the current Price to Sales Ratio (P/S).
  • Regencell Bioscience Holdings Ltd 52-week low Price to Sales Ratio (P/S) is -0.15 on June 05, 2023, which is NA below the current Price to Sales Ratio (P/S).
  • Regencell Bioscience Holdings Ltd average Price to Sales Ratio (P/S) for the last 52 weeks is -0.08.
NASDAQ: RGC

Regencell Bioscience Holdings Ltd

CEO Mr. Yat-Gai Au
IPO Date July 16, 2021
Location Hong Kong
Headquarters First Commercial Building, Causeway Bay, Hong Kong
Employees 12
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

EGRX

Eagle Pharmaceuticals Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

PROC

Procaps Group SA

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email